{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:38:31Z","timestamp":1791290311353,"version":"4.3.0"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T00:00:00Z","timestamp":1242864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold>Nucleolin is a major nucleolar argyrophilic protein involved in carcinogenesis. There are only few studies on its tissue expression in human cancer and none in melanoma. We aimed at exploring this protein and its prognostic impact in cutaneous melanocytic lesions.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>We studied 193 cases including benign, dysplastic and malignant melanocytic lesions. Nuclear positivity was evaluated by immunohistochemistry and quantified by automated image analysis.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Most dysplastic and malignant lesions showed high percentages of cells with abnormal patterns of nuclear positivity (Abn+N) consisting in multiple, irregular, positive dots (ID+) and a coarse, irregularly positive nucleoplasm (CNpl+) or both (ID+CNpl+). The patterns CNpl+ and\/or ID+CNpl+ were never observed in benign lesions, in which ID+ were also virtually absent. Abn+N% was significantly lower in dysplastic nevi than in primary melanomas and metastases and in primary melanomas than in metastases (p\u2003&lt;\u20030.05). Furthermore, Abn+N was the second powerful prognostic discriminator, after melanoma thickness, and a significantly lower survival was observed in vertical growth phase melanoma patients showing Abn+N in more than 50% of melanoma cells.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold>An altered nuclear nucleolin expression seems to accompany melanoma progression. Further investigation on nucleolin functionality and subcellular trafficking could add information on its altered role in melanoma.<\/jats:p>","DOI":"10.1111\/j.1600-0560.2008.01126.x","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T15:53:56Z","timestamp":1242662036000},"page":"637-646","source":"Crossref","is-referenced-by-count":18,"title":["Nucleolin protein expression in cutaneous melanocytic lesions"],"prefix":"10.1111","volume":"36","author":[{"given":"Vasileios","family":"Mourmouras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Cevenini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cosci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Epistolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Biagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Barbagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Luzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Miracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,21]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"497","article-title":"The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells","volume":"73","author":"Derenzini M","year":"1995","journal-title":"Lab Invest"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.14.1911"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-4328(99)00067-0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011053"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M513335200"},{"key":"e_1_2_6_7_2","first-page":"23","article-title":"Expression and intranuclear distribution of nucleolin in estrogen receptor\u2010negative and estrogen receptor\u2010positive breast cancers in women measured by laser scanning cytometry","volume":"52","author":"Masiuk M","year":"2006","journal-title":"Ann Acad Med Stetin"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1182\/blood-2006-08-043257","article-title":"Overexpression of nucleolin in chronic lymphocytic leukaemia cells induces stabilization of bcl2 mRNA","volume":"109","author":"Otake Y","year":"2007","journal-title":"Blood"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/1-4020-5466-1_7"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90512-5"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2006.00522.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601046"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod64.5.1516"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.008771"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E06-08-0751"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-8-66"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207637200"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.07.034"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-197"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20501"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0361"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.16.6014-6022.2002"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.05.022"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002310"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm1027"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1927"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002518"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198507086.001.0001","volume-title":"Principles of multivariate analysis: a user\u2019s perspsective","author":"Krzanowski WJ","year":"2000"},{"key":"e_1_2_6_29_2","volume-title":"Applied survival analysis","author":"Hosmer DW","year":"1999"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0459-7"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050481"},{"key":"e_1_2_6_32_2","first-page":"107","article-title":"PCNA expression and nucleolar organizer regions in malignant melanoma and nevus cell nevus","volume":"40","author":"Kanoko M","year":"1994","journal-title":"Kobe J Med Sci"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199502000-00003"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1995.tb01395.x"},{"key":"e_1_2_6_35_2","first-page":"420","article-title":"Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours","volume":"95","author":"Naik R","year":"1997","journal-title":"J Indian Med Assoc"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199810000-00008"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2005.00322.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200306000-00002"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbaexp.2003.09.012"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.3.2.684"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0560.2008.01126.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0560.2008.01126.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:06:37Z","timestamp":1710338797000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0560.2008.01126.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,21]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1600-0560.2008.01126.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0560.2008.01126.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,21]]}}}